Sign inGet started

Clayton Sean M.

Insider CIK 1911998 · HZNP EVP, General Counsel

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-0611,499— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-065,749— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-0628,258— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-0622,997— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-065,749— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer2023-10-062023-10-06745$116.50 $86.8K0SEC↗
HZNP Horizon Therapeutics Publi D To issuer2023-10-062023-10-067,655$116.50 $891.8K0SEC↗
HZNP Horizon Therapeutics Publi M Exercise deriv2023-03-012023-03-0614,129— $028,258SEC↗
HZNP Horizon Therapeutics Publi F Tax w/h2023-03-012023-03-067,032$110.34 $775.9K7,376SEC↗
HZNP Horizon Therapeutics Publi M Exercise2023-03-012023-03-0614,129— $014,408SEC↗
HZNP Horizon Therapeutics Publi A Award deriv2023-01-042023-01-0622,997— $022,997SEC↗
HZNP Horizon Therapeutics Publi P Buy2022-08-042022-08-08745$66.67 $49.7K745SEC↗
HZNP Horizon Therapeutics Publi A Award deriv2022-03-012022-03-0242,387— $042,387SEC↗